Key Metrics
4.5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.84
5-Year SI
5-year SI
- 0.86 2-year SI
- 0.84 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
1.17
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
1 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
96%
4 to 6 months
4%
7 to 9 months
0%
Above 9 months
0%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Human papillomavirus
- Cross-sectional study
- Assay
- Virus
- Immunization
- Antigen
- Vaccine strain
- Influenza vaccine
- Streptococcus pneumoniae
- Immunotherapy
- Cardiometabolic disease
- Machine learning
- Serotype
- Nitric oxide
- Schedule
- Social media
- Rubella
- Hepatitis B
- Clinical trial
- Glycoprotein
Journal Specifications
| Overview | |
| Publisher | MDPI |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | CHF 2200 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 6 |
| Article Processing Charges | CHF 2200 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
Planning to publish in Vaccines ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Engineering Escherichia coli-Derived Nanoparticles for Vaccine Development
- 18 Nov 24
- Vaccines
-
Full paper
First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster
- 18 Nov 24
- Vaccines
-
Full paper
Correction: Huang et al. Next Generation of Computationally Optimized Broadly Reactive HA Vaccines Elicited Cross-Reactive Immune Responses and Provided Protection against H1N1 Virus Infection. Vaccines 2021, 9, 793
- 15 Nov 24
- Vaccines
-
Full paper
Milk-Derived Extracellular Vesicles: A Novel Perspective on Comparative Therapeutics and Targeted Nanocarrier Application
- 15 Nov 24
- Vaccines
-
Full paper
Factors Predicting COVID-19 Vaccine Effectiveness and Longevity of Humoral Immune Responses
- 15 Nov 24
- Vaccines
-
Full paper
The Immunologic Downsides Associated with the Powerful Translation of Current COVID-19 Vaccine mRNA Can Be Overcome by Mucosal Vaccines
- 14 Nov 24
- Vaccines
Scite analysis
Powered by scite_
8k articles received 98.5k citations see all
- 5,749 Supporting
- 90,234 Mentioning
- 1,061 Contrasting
Editorial notices
- 4 Retractions
- 0 Withdrawals
- 20 Corrections
- 8 Errata
- 0 Expression of Concern
FAQs
How long has Vaccines been actively publishing?
Vaccines has been in operation since 2013 till date.
What is the publishing frequency of Vaccines ?
Vaccines published with a Monthly frequency.
How many articles did Vaccines publish last years ?
In 2023, Vaccines published 1816 articles.
What is the eISSN & pISSN for Vaccines ?
For Vaccines,eISSN is 2076-393X and pISSN is2076-393X.
What is Citescore for Vaccines ?
Citescore for Vaccines is 4.5.
What is SNIP score for Vaccines ?
SNIP score for Vaccines is 1.17.
Who is the publisher of Vaccines ?
MDPI is the publisher of Vaccines.